N-[(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexyl]-6-(trifluoromethyl)pyridine-3-carboxamide;cis-(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexan-1-amine;6-(trifluoromethyl)pyridine-3-carboxylic acid;hydrochloride
C46H71ClF6N6O3 — CID 158867208
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexyl]-6-(trifluoromethyl)pyridine-3-carboxamide;cis-(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexan-1-amine;6-(trifluoromethyl)pyridine-3-carboxylic acid;hydrochloride
N-[(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexyl]-6-(trifluoromethyl)pyridine-3-carboxamide;cis-(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexan-1-amine;6-(trifluoromethyl)pyridine-3-carboxylic acid;hydrochloride (PubChem CID 158867208) has the molecular formula C46H71ClF6N6O3 and a molecular weight of 905.55 g/mol. Its IUPAC name is N-[(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexyl]-6-(trifluoromethyl)pyridine-3-carboxamide;cis-(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexan-1-amine;6-(trifluoromethyl)pyridine-3-carboxylic acid;hydrochloride.
Molecular Properties
| Compound Name | N-[(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexyl]-6-(trifluoromethyl)pyridine-3-carboxamide;cis-(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexan-1-amine;6-(trifluoromethyl)pyridine-3-carboxylic acid;hydrochloride |
|---|---|
| PubChem CID | 158867208 |
| Molecular Formula | C46H71ClF6N6O3 |
| Molecular Weight | 905.55 g/mol |
| Exact Mass | 904.52 |
| IUPAC Name | N-[(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexyl]-6-(trifluoromethyl)pyridine-3-carboxamide;cis-(1R,2S)-2-[(3-butylpiperidin-1-yl)methyl]cyclohexan-1-amine;6-(trifluoromethyl)pyridine-3-carboxylic acid;hydrochloride |
| SMILES | CCCCC1CCCN(C[C@@H]2CCCC[C@H]2N)C1.CCCCC1CCCN(C[C@@H]2CCCC[C@H]2NC(=O)c2ccc(C(F)(F)F)nc2)C1.Cl.O=C(O)c1ccc(C(F)(F)F)nc1 |
| InChI | InChI=1S/C23H34F3N3O.C16H32N2.C7H4F3NO2.ClH/c1-2-3-7-17-8-6-13-29(15-17)16-19-9-4-5-10-20(19)28-22(30)18-11-12-21(27-14-18)23(24,25)26;1-2-3-7-14-8-6-11-18(12-14)13-15-9-4-5-10-16(15)17;8-7(9,10)5-2-1-4(3-11-5)6(12)13;/h11-12,14,17,19-20H,2-10,13,15-16H2,1H3,(H,28,30);14-16H,2-13,17H2,1H3;1-3H,(H,12,13);1H/t17?,19-,20+;14?,15-,16+;;/m00../s1 |
| InChIKey | TXKOJUAUNORBDI-KRDHXTNSSA-N |
| XLogP | 10.92 |
| TPSA | 124.68 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 62 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 905.55 |
| LogP ≤ 5 | 10.92 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158867208 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.